Revolution Medicines (BMV:RVMD) has updated its average one-year price target to MX$3,921.29 per share, representing a 30.66% increase from the previous estimate of MX$3,001.13 on August 3, 2026. Analyst targets range from MX$2,837.87 to MX$5,274.21 per share.
In the last quarter, 273 funds reported positions in Revolution Medicines, marking an 8.33% increase with 22 additional owners. Institutional ownership rose by 22.68% to 61,778,000 shares, with an average portfolio weight of 0.54% in RVMD.
Key stakeholders include Farallon Capital Management, holding 13,551,000 shares (20.35% ownership) but decreasing its stake slightly by 0.40%. Conversely, Baker Bros. Advisors increased its holdings from 9,555,000 to 11,443,000 shares (17.18% ownership), a 16.50% rise. Darwin Global Management significantly boosted its shares from 2,211,000 to 10,630,000 (15.96% ownership), marking a 901.64% increase.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
